Physician Assistant · Wilson, NC
NPI
1992165104
Since 2016
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1806 Glendale Dr SW
Wilson, NC, 27893
Phone (252) 243-0566
Groups this clinician bills Medicare through
Medicare paid, 2024
$151K
4,802 services
Medicare patients, 2024
962
Average age 75
Drug cost, 2024
$2.8M
3,671 prescriptions
Company payments, 2025
$1,597
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cassie McGee was code 17003 (destruction skin lesion), 1,751 times for 269 patients. In total Cassie McGee billed 4,802 services in 34 codes, and Medicare paid $151K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 1,751 | 269 | $3.72 | $6,515 |
| 17000 Destruction Skin Lesion | Office | 510 | 356 | $27.80 | $14K |
| 99212 Office E&M - Established | Office | 401 | 297 | $28.84 | $12K |
| 99214 Office E&M - Established | Office | 378 | 266 | $65.72 | $25K |
| 99213 Office E&M - Established | Office | 375 | 299 | $47.86 | $18K |
| 17110 Destruction Skin Lesion | Office | 343 | 252 | $60.18 | $21K |
| 11102 Skin Biopsy | Office | 254 | 229 | $49.08 | $12K |
| 99202 Office E&M - New | Office | 189 | 189 | $31.79 | $6,008 |
| 99204 Office E&M - New | Office | 171 | 171 | $78.43 | $13K |
| 96372 Injection Administration | Office | 69 | 23 | $7.85 | $542 |
| 99203 Office E&M - New | Office | 68 | 68 | $53.21 | $3,619 |
| 11103 Skin Biopsy | Office | 60 | 46 | $27.32 | $1,639 |
| 17111 Destruction Skin Lesion | Office | 32 | 25 | $69.01 | $2,208 |
| 17282 Destruction Skin Lesion | Office | 30 | 24 | $116.43 | $3,493 |
| 17004 Destruction Skin Lesion | Office | 30 | 29 | $94.43 | $2,833 |
By year: 2022 $1,834 for 39 services; 2023 $117K for 3,163 services; 2024 $151K for 4,802 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cassie McGee prescribed most often to Medicare patients was Clobetasol Propionate, with 660 prescriptions and refills. In total Cassie McGee wrote 3,671 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 660 | 698 | 329 | $28K |
| Hydrocortisone Generic | 380 | 391 | 207 | $2,092 |
| Triamcinolone Acetonide Generic | 372 | 383 | 233 | $5,445 |
| Ketoconazole Generic | 314 | 323 | 150 | $5,096 |
| Ammonium Lactate Generic | 179 | 181 | 120 | $4,198 |
| Dupixent Pen Dupilumab | 167 | 167 | 32 | $627K |
| Gabapentin Generic | 132 | 141 | 41 | $1,417 |
| Clindamycin Phosphate Generic | 125 | 134 | 64 | $3,504 |
| Doxycycline Hyclate Generic | 116 | 126 | 57 | $2,719 |
| Nystatin Generic | 112 | 114 | 63 | $1,295 |
| Tacrolimus Generic | 80 | 81 | 46 | $15K |
| Mometasone Furoate Generic | 75 | 77 | 45 | $1,680 |
| Betamethasone Valerate Generic | 70 | 76 | 45 | $1,910 |
| Minocycline Hcl Generic | 53 | 65 | 24 | $921 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 48 | 48 | Under 11 | $395K |
Brand drugs: 550 claims; generic drugs: 3,121 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cassie McGee $1,597 ($1,597 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $566.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 29 | $566 |
| Janssen Biotech, Inc. JNJ | 14 | $365 |
| E.R. Squibb & Sons, L.L.C. BMY | 12 | $232 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $195 |
| LEO Pharma Inc. | 4 | $88.28 |
| Arcutis Biotherapeutics, Inc. ARQT | 2 | $37.8 |
| UCB, Inc. UCB.BR | 1 | $37.12 |
| Amgen Inc. AMGN | 2 | $32.04 |
| Lilly USA, LLC LLY | 1 | $26.18 |
| Galderma Laboratories, L.P. GALD.SW | 1 | $17.62 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.